• Genoa in the News

Genoa Healthcare® Chief Executive Officer provides industry outlook in Chain Drug Review article

Feb 2nd, 2024

In the health care industry in 2024, pharmacy teams will continue to play a critical role in providing care in areas with limited access to pharmacy services.

Genoa Healthcare Chief Executive Officer Todd Gustin discussed the expanded role of the pharmacist and what that means for improving access to care in Chain Drug Review’s recent industry outlook article.

“Genoa will continue filling gaps in care for [medically underserved] populations, focusing on providing care in areas where access to pharmacy services is limited,” said Gustin. “Often called pharmacy deserts, these are areas where patients experience significant barriers to accessing their needed medications due to their geographic location and distance from a pharmacy.”

You can read the full article here.

Let’s connect

Want to learn more about offering Genoa pharmacy services to your consumers? Fill out the form below and we’ll be in touch.

"*" indicates required fields

Name*
Does your organization currently partner with Genoa?*
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...